The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.35
Bid: 6.20
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.30 (4.839%)
Open: 6.35
High: 0.00
Low: 0.00
Prev. Close: 6.35
MTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Loan Agreements

14 Nov 2019 15:14

RNS Number : 4777T
Mothercare PLC
14 November 2019
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN EU REGULATION NO 596/2014 AND IS MADE IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF THAT REGULATION

 

Convertible Loan Agreements

Further to the announcements of 5 November 2019, the Board of Mothercare plc (the "Company") is pleased to confirm that it has entered into definitive agreements in relation to the provision of £5.5m of convertible unsecured loans (the "2019 Shareholder Loans"). The 2019 Shareholder Loans have been provided by related and / or controlled entities of Lombard Odier Asset Management (Europe) Limited and Richard Griffiths, two of Mothercare's existing investors, and as set out in the previous announcement, these are on substantially the same terms as the convertible unsecured loans provided in May 2018 (the "2018 Loan Notes"), with the exception of the conversion price of 10 pence per share. If held to the last conversion date of 31 May 2021, the 2019 Shareholder Loans may convert into up to 70.6m ordinary shares in Mothercare plc.

The provision of the 2019 Shareholder Loans and the placing of new ordinary shares announced by the Company on 5 November has resulted in an adjustment to the conversion price applicable in respect of the 2018 Shareholder Loans. As a result, if held to the last conversion date 31 May 2021, the 2018 Shareholder Loans may convert into up to 119.1m ordinary shares in Mothercare plc.

The 2019 Shareholder Loans are convertible into ordinary shares in the Company at the option of the relevant shareholder, conditional upon, among other things, the approval by the Company's shareholders of the conversion as Related Party Transactions under the Listing Rules and, in relation to the Richard Griffiths and controlled entities' holding only, a Rule 9 Whitewash being granted under the City Code on Take-overs & Mergers. The Company has an obligation to procure the satisfaction of all conditions to conversion within 10 weeks of the delivery of a conversion notice and accordingly, the Company will convene the necessary general meeting of its shareholders to approve these arrangements in due course. 

The Company has drawn down the 2019 Shareholder Loans in full and expects to receive the £5.5m made available pursuant to the 2019 Shareholder Loans on 15 November 2019. At the point from which the Shareholder Loans are drawn down, and as previously agreed with the Company, Numis' standby underwriting commitment will be formally reduced from £25m to £20m. All other elements of the standby underwriting commitment remain the same.

 

ENDS

Mothercare plc

Mark Newton-Jones, Chief Executive Officer 01923 206004

Glyn Hughes, Chief Financial Officer

Numis Securities Ltd (Financial Adviser)

Luke Bordewich 020 7260 1000

Oliver Cox

MHP Communications:

Simon Hockridge, Tim Rowntree, Alistair de Kare-Silver 020 3128 8789

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRCKQDDPBDDBDD
Date   Source Headline
13th Mar 20247:50 amGNWBlock listing Interim Review
6th Dec 20239:32 amGNWHolding(s) in Company
28th Nov 202310:13 amGNWHolding(s) in Company
24th Nov 20237:00 amRNSInterim Results
23rd Oct 20231:43 pmGNWAGM Statement
25th Sep 20239:15 amGNWDirector/PDMR Shareholding
25th Sep 20237:00 amGNWAnnual Report and Accounts and Notice of AGM
22nd Sep 202312:33 pmGNWDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSFull Year Results 2023
13th Sep 20237:19 amGNWBlock listing Interim Review
4th Jul 20239:43 amGNWHolding(s) in Company
9th Jun 20237:00 amGNWDirectorate change
4th May 20237:00 amGNWPre-close Trading Update
27th Mar 20238:06 amGNWDirector/PDMR Shareholding
13th Mar 20238:00 amGNWBlock listing Interim Review
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
8th Feb 202310:45 amRNSDirector/PDMR Shareholding
3rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20239:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSFurther re: Appointment of Chief Executive Officer
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim results announcement
24th Nov 20227:00 amGNWAppointment of Chief Executive Officer
21st Nov 20224:36 pmRNSPrice Monitoring Extension
13th Oct 202212:38 pmGNWAGM Statement
16th Sep 20228:04 amGNWAnnual Report and Accounts and Notice of AGM
14th Sep 20221:31 pmGNWDirector/PDMR Shareholding
13th Sep 20224:40 pmRNSSecond Price Monitoring Extn
13th Sep 20224:35 pmRNSPrice Monitoring Extension
13th Sep 20224:12 pmGNWBlock listing Interim Review
13th Sep 20223:38 pmRNSFull Year Results 2022
16th May 20224:41 pmRNSSecond Price Monitoring Extn
16th May 20224:35 pmRNSPrice Monitoring Extension
4th May 20224:40 pmRNSSecond Price Monitoring Extn
4th May 20224:36 pmRNSPrice Monitoring Extension
11th Apr 20227:00 amGNWPre-close Trading Update
14th Mar 20229:12 amGNWBlock listing Interim Review
9th Mar 20227:00 amRNSStatement re Russia
24th Feb 20223:36 pmGNWHolding(s) in Company
24th Feb 202212:38 pmGNWHolding(s) in Company
4th Jan 20228:42 amGNWHolding(s) in Company
25th Nov 20217:00 amRNSInterim results announcement
27th Oct 202110:52 amGNWHolding(s) in Company
13th Sep 20218:15 amGNWBlock listing Interim Review
9th Sep 202111:49 amGNWAGM Statement and trading update
7th Sep 20217:10 amGNWHolding(s) in Company
10th Aug 202111:30 amGNWNotice of Annual General Meeting and Annual Report and Accounts
3rd Aug 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.